Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

492.38
+3.300.67%
Pre-market: 490.90-1.4800-0.30%07:03 EDT
Volume:615.77K
Turnover:303.42M
Market Cap:24.40B
PE:46.80
High:495.51
Open:493.18
Low:484.00
Close:489.08
52wk High:625.99
52wk Low:228.00
Shares:49.56M
Float Shares:48.15M
Volume Ratio:1.17
T/O Rate:1.28%
Dividend:0.80
Dividend Rate:0.16%
EPS(TTM):10.52
EPS(LYR):10.52
ROE:25.75%
ROA:11.87%
PB:10.95
PE(LYR):46.80

Loading ...

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 23

Nyse Order Imbalance 162570.0 Shares on Sell Side

THOMSON REUTERS
·
Mar 21

Press Release: Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability

Dow Jones
·
Mar 20

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update

GlobeNewswire
·
Mar 20

Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs

prnewswire
·
Mar 18

Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting

GlobeNewswire
·
Mar 18

A Look At Carpenter Technology (CRS) Valuation After A Strong Multi Year Share Price Run

Simply Wall St.
·
Mar 16

Press Release: Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights

Dow Jones
·
Mar 11

Is Strong Q2 Beat And Higher Guidance Altering The Investment Case For Carpenter Technology (CRS)?

Simply Wall St.
·
Mar 04

Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases

prnewswire
·
Mar 04

Carpenter Tech Initiated at Positive by Susquehanna

Dow Jones
·
Mar 03

Susquehanna Initiates Carpenter Technology at Positive With $470 Price Target

MT Newswires Live
·
Mar 03

XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication

prnewswire
·
Mar 02

Carpenter Technology CEO Shift Puts Capital Projects And Growth Priorities In Focus

Simply Wall St.
·
Mar 01

Carpenter Technology SVP, General Counsel and Secretary James D. Dee Disposes of Common Shares

Reuters
·
Feb 26

Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026

GlobeNewswire
·
Feb 25